LOC100130000: A Drug Target / Disease Biomarker (G100130000)

LOC100130000: A Drug Target / Disease Biomarker

LOC100130000 is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell division and has been identified as a potential drug target in the field of cancer.

LOC100130000 is a transcription factor that is involved in the regulation of gene expression. It is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is highly expressed in the liver and has been identified as a potential drug target in the field of cancer.

One of the key functions of LOC100130000 is its role in cell division. It is a key regulator of the G1/S transition, which is the stage of cell division where the cell prepares for cell division. During the G1/S transition, LOC100130000 helps to ensure that the cell has the necessary components for cell division, such as the RNA molecule encoding the protein RNA polymerase II.

LOC100130000 is also involved in the regulation of cell growth and differentiation. It helps to ensure that cells are able to divide and grow in an orderly fashion, and it also plays a role in the regulation of cell shape and movement.

In addition to its role in cell division and growth, LOC100130000 is also involved in the regulation of cell survival. It helps to ensure that cells are able to adapt to changes in their environment and survive in the face of these changes.

The potential drug target that LOC100130000 is a good candidate for is cancer. Cancer is a disease that is characterized by the uncontrolled growth and division of cells. LOC100130000 is involved in the regulation of cell division and has been identified as a potential drug target in the field of cancer.

One of the potential benefits of targeting LOC100130000 is its potential to inhibit cell division and disrupt the growth and expansion of cancer cells. This could be done through the use of small molecules or antibodies that target LOC100130000 and prevent it from interacting with its downstream targets.

Another potential benefit of targeting LOC100130000 is its potential to treat certain types of cancer. For example, LOC100130000 has been shown to be highly expressed in liver cancer cells and has been identified as a potential drug target for these cancers. Targeting LOC100130000 with small molecules or antibodies that disrupt its function could be an effective way to treat liver cancer.

LOC100130000 is also a good candidate for a potential drug that targets the G1/S transition. The G1/S transition is a critical stage of cell division and LOC100130000 plays a key role in ensuring that the cell has the necessary components for this transition. Targeting LOC100130000 during the G1/S transition with small molecules or antibodies that disrupt its function could be an effective way to treat certain types of cancer.

In conclusion, LOC100130000 is a protein that is involved in the regulation of cell division and has been identified as a potential drug target in the field of cancer. Its functions in cell division and growth, as well as its role in cell survival, make it an attractive candidate for a potential drug. The use of small molecules or antibodies that target LOC100130000

Protein Name: Phosphodiesterase 4D Interacting Protein Pseudogene

The "LOC100130000 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100130000 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC100130207 | LOC100130285 | LOC100130298 | LOC100130331 | LOC100130452 | LOC100130463 | LOC100130548 | LOC100130587 | LOC100130691 | LOC100130698 | LOC100130744 | LOC100130748 | LOC100130872 | LOC100130899 | LOC100130938 | LOC100130987 | LOC100130992 | LOC100131096 | LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532 | LOC100131626 | LOC100131635 | LOC100131859 | LOC100131877 | LOC100131943 | LOC100132004 | LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841